Drugs / JE vaccine

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01150942 Aug 2010 → Sep 2012 Japanese encephalitis Boryung Pharmaceutical Co., Ltd Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as JE vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01150942 ↗
Known as ENCEVAC “inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children” PMID 25567119 ↗ Jan 2015
Modality Vaccine “Vero cell culture-derived, inactivated vaccine” PMID 25567119 ↗ Jan 2015
Route Intramuscular “3 times, IM” NCT01150942 ↗